The Economic and Humanistic Burden of Pediatric-Onset Multiple Sclerosis
**Background:** Multiple sclerosis (MS) is a chronic inflammatory autoimmune disease of the central nervous system. Pediatric-onset MS (POMS), defined as onset of MS before 18 years of age, is estimated to account for 2% to 5% of the MS population worldwide. **Objectives:** To conduct a literature r...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Columbia Data Analytics, LLC
2022-10-01
|
| Series: | Journal of Health Economics and Outcomes Research |
| Online Access: | https://doi.org/10.36469/001c.37992 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1823860367777857536 |
|---|---|
| author | Nupur Greene Lita Araujo Cynthia Campos Hannah Dalglish Sarah Gibbs Irina Yermilov |
| author_facet | Nupur Greene Lita Araujo Cynthia Campos Hannah Dalglish Sarah Gibbs Irina Yermilov |
| author_sort | Nupur Greene |
| collection | DOAJ |
| description | **Background:** Multiple sclerosis (MS) is a chronic inflammatory autoimmune disease of the central nervous system. Pediatric-onset MS (POMS), defined as onset of MS before 18 years of age, is estimated to account for 2% to 5% of the MS population worldwide.
**Objectives:** To conduct a literature review focused on the healthcare resource utilization and cost as well as quality-of-life (QOL) outcomes among patients with POMS.
**Methods:** We conducted a systematic literature review of English-language studies published after September 2010 in MEDLINE and Embase to describe the global economic healthcare resource utilization and costs and humanistic (QOL) burden in patients with POMS.
**Results:** We found 11 studies that reported on healthcare resource utilization, cost, or insurance coverage and 36 studies that reported on QOL outcomes in patients with POMS. Patients with POMS had higher rates of primary care visits (1.41 [1.29-1.54]), hospital visits (10.74 [8.95-12.90]), and admissions (rate ratio, 4.27 [2.92-6.25];OR, 15.2 [12.0-19.1]) compared with healthy controls. Mean per-patient costs in the United States were $5907 across all settings per year of follow-up between 2002 and 2012; mean costs per hospital stay were $38 543 (in 2015 USD) between 2004 and 2013. Three studies reported psychosocial scores between 71.59 and 79.7, and 8 studies reported physical health scores between 74.62 to 82.75 using the Pediatric Quality of Life Measurement Model (PedsQLTM). Twelve studies used the PedsQL™ Multidimensional Fatigue Scale. Mean scores on the self-reported general fatigue scale ranged from 63.15 to 78.5. Quality-of-life scores were lower than those of healthy controls.
**Discussion:** Our review presents a uniquely broad and recent overview of the global economic and humanistic burden of patients with POMS. Additional research on healthcare resource utilization and cost would provide a more robust understanding of the economic burden in this population.
**Conclusions:** Healthcare resource utilization and costs are high in this population, and patients report reduced QOL and significant fatigue compared with healthy children and adolescents. |
| format | Article |
| id | doaj-art-b4c03337508a45eb99ff5ec3d6a17c8c |
| institution | Kabale University |
| issn | 2327-2236 |
| language | English |
| publishDate | 2022-10-01 |
| publisher | Columbia Data Analytics, LLC |
| record_format | Article |
| series | Journal of Health Economics and Outcomes Research |
| spelling | doaj-art-b4c03337508a45eb99ff5ec3d6a17c8c2025-02-10T16:13:05ZengColumbia Data Analytics, LLCJournal of Health Economics and Outcomes Research2327-22362022-10-0192The Economic and Humanistic Burden of Pediatric-Onset Multiple SclerosisNupur GreeneLita AraujoCynthia CamposHannah DalglishSarah GibbsIrina Yermilov**Background:** Multiple sclerosis (MS) is a chronic inflammatory autoimmune disease of the central nervous system. Pediatric-onset MS (POMS), defined as onset of MS before 18 years of age, is estimated to account for 2% to 5% of the MS population worldwide. **Objectives:** To conduct a literature review focused on the healthcare resource utilization and cost as well as quality-of-life (QOL) outcomes among patients with POMS. **Methods:** We conducted a systematic literature review of English-language studies published after September 2010 in MEDLINE and Embase to describe the global economic healthcare resource utilization and costs and humanistic (QOL) burden in patients with POMS. **Results:** We found 11 studies that reported on healthcare resource utilization, cost, or insurance coverage and 36 studies that reported on QOL outcomes in patients with POMS. Patients with POMS had higher rates of primary care visits (1.41 [1.29-1.54]), hospital visits (10.74 [8.95-12.90]), and admissions (rate ratio, 4.27 [2.92-6.25];OR, 15.2 [12.0-19.1]) compared with healthy controls. Mean per-patient costs in the United States were $5907 across all settings per year of follow-up between 2002 and 2012; mean costs per hospital stay were $38 543 (in 2015 USD) between 2004 and 2013. Three studies reported psychosocial scores between 71.59 and 79.7, and 8 studies reported physical health scores between 74.62 to 82.75 using the Pediatric Quality of Life Measurement Model (PedsQLTM). Twelve studies used the PedsQL™ Multidimensional Fatigue Scale. Mean scores on the self-reported general fatigue scale ranged from 63.15 to 78.5. Quality-of-life scores were lower than those of healthy controls. **Discussion:** Our review presents a uniquely broad and recent overview of the global economic and humanistic burden of patients with POMS. Additional research on healthcare resource utilization and cost would provide a more robust understanding of the economic burden in this population. **Conclusions:** Healthcare resource utilization and costs are high in this population, and patients report reduced QOL and significant fatigue compared with healthy children and adolescents.https://doi.org/10.36469/001c.37992 |
| spellingShingle | Nupur Greene Lita Araujo Cynthia Campos Hannah Dalglish Sarah Gibbs Irina Yermilov The Economic and Humanistic Burden of Pediatric-Onset Multiple Sclerosis Journal of Health Economics and Outcomes Research |
| title | The Economic and Humanistic Burden of Pediatric-Onset Multiple Sclerosis |
| title_full | The Economic and Humanistic Burden of Pediatric-Onset Multiple Sclerosis |
| title_fullStr | The Economic and Humanistic Burden of Pediatric-Onset Multiple Sclerosis |
| title_full_unstemmed | The Economic and Humanistic Burden of Pediatric-Onset Multiple Sclerosis |
| title_short | The Economic and Humanistic Burden of Pediatric-Onset Multiple Sclerosis |
| title_sort | economic and humanistic burden of pediatric onset multiple sclerosis |
| url | https://doi.org/10.36469/001c.37992 |
| work_keys_str_mv | AT nupurgreene theeconomicandhumanisticburdenofpediatriconsetmultiplesclerosis AT litaaraujo theeconomicandhumanisticburdenofpediatriconsetmultiplesclerosis AT cynthiacampos theeconomicandhumanisticburdenofpediatriconsetmultiplesclerosis AT hannahdalglish theeconomicandhumanisticburdenofpediatriconsetmultiplesclerosis AT sarahgibbs theeconomicandhumanisticburdenofpediatriconsetmultiplesclerosis AT irinayermilov theeconomicandhumanisticburdenofpediatriconsetmultiplesclerosis AT nupurgreene economicandhumanisticburdenofpediatriconsetmultiplesclerosis AT litaaraujo economicandhumanisticburdenofpediatriconsetmultiplesclerosis AT cynthiacampos economicandhumanisticburdenofpediatriconsetmultiplesclerosis AT hannahdalglish economicandhumanisticburdenofpediatriconsetmultiplesclerosis AT sarahgibbs economicandhumanisticburdenofpediatriconsetmultiplesclerosis AT irinayermilov economicandhumanisticburdenofpediatriconsetmultiplesclerosis |